Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its ...

Get the latest Trinity Biotech plc (TRIB) stock news and headlines to help you in your trading and investing decisions.

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Review Trinity Biotech PLC ADR (TRIB:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

DUBLIN, July 01, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), currently trading at $0.55 per share with a market capitalization of approximately $10 million, has received World Health Organization approval for ...

Read about Trinity Biotech PLC ADR (TRIB:XNAS) stock and today's latest news and financial updates.

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), currently trading at $0.55 per share with a market capitalization of approximately $10 million, has received World Health Organization approval for ...